Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Roderick Tung
- Study ID
- NCT06635863
- Phase
- PHASE4
- Status
- Enrolling By Invitation
Conditions
- Arrhythmogenic Inflammatory Cardiomyopathy
- Non-ischemic Cardiomyopathy
- Ventricular Arrythmia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Prednisone 40mg — DRUGPrednisone 40mg x 8weeks
Study Details
Ventricular tachycardia (VT, a potentially fatal condition where the ventricle of the heart beats rapidly) superimposed on non-ischemic cardiomyopathy (NICM, a disease of heart with broad etiologies except coronary artery disease). This disease has been associated with inflammation in the heart. The purpose of this study is to assess the benefit of immunosuppressive therapy to suppress the VT, improve heart function, avoid invasive intervention and hospitalization. Positron Emission Tomography (PET) imaging shows inflammation in the heart. After enrollment, baseline tests (including physical exams, blood tests, genetic test, electrocardiography, echocardiography) will be done. Next, will be an 8-week medication regimen which contains either immunosuppressive drugs or standard GDMT without immunosuppressant medication. Some of the examinations will be repeated during the study to evaluate the treatment response and monitor any adverse events.
Key Dates
- Start date
- Nov 1, 2024
- Status verified
- Dec 2024
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ImmunosuppressionPrednisone 40mg x 8weeks + GDMT
- No Intervention: Standard of CareGDMT alone
Primary Outcome Measure
Burden of ventricular arrhythmias [ Time Frame: 12 months (8 weeks and 6 months) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner - University Medical Center, Phoenix campus | Phoenix | Arizona | 85006 | - |
Find similar trials in Phoenix, AZ
Related Studies
- Development of CIRC TechnologiesRecruiting · The Cleveland Clinic · Cleveland, Ohio
- Cardiovascular Multimodality Imaging StudyRecruiting · Montefiore Medical Center · The Bronx, New York
- The Comparative Advantage of the Optrell Mapping Catheter in Ventricular Arrhythmias From the Papillary MusclesRecruiting · Northwell Health · New Hyde Park, New York